{
  "content": "Rate control versus rhythm control\nSeveral clinical trials27, 28, 29, 30 comparing the strategies of rhythm control with rate control for atrial fibrillation, as well as meta-analyses,31, 32, 33, 34 have shown no significant differences between the two strategies with respect to mortality, major bleeding, and thromboembolic events, at least on an intention-to-treat analysis. A non-significant trend was seen for excess mortality with a rhythm-control strategy in the AFFIRM trial.29 For functional endpoints, four trials have shown \nConcomitant disease",
  "source": "https://www.sciencedirect.com/science/article/abs/pii/S0140673607613002",
  "chunk_id": "d358ad32-b2fe-41df-8d0b-d5c1dd107184",
  "similarity_score": 0.3952822685241699,
  "query": "amiodarone versus beta-blockers atrial fibrillation randomized controlled trial effectiveness rhythm control rate control",
  "rank": 30,
  "title": "Management of atrial fibrillation",
  "authors": "Prof Gregory YH Lip, Prof Hung-Fat Tse",
  "year": "2007",
  "journal": "The Lancet",
  "reference": "Lip, G. Y. H., & Tse, H.-F. (2007). Management of atrial fibrillation. The Lancet, 370(9587), 604-618.",
  "doi": "Not available",
  "chunk_index": 6,
  "total_chunks": 50,
  "retrieved_at": "2025-07-24T21:57:43.521843"
}